Navigation Links
Saint-Gobain's New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition

CLEARWATER, Fla., June 15, 2011 /PRNewswire/ -- Saint-Gobain Performance Plastics has expanded its line of thermoplastic elastomer (TPE) tubing with the addition of new C-Flex® ULTRA pump tubing, a product designed specifically to perform in demanding biopharmaceutical applications such as pumping, single-use assemblies, process filling and sampling.

Produced from C-Flex® resin that has been validated by pharmaceutical manufacturers for more than two decades, C-Flex® ULTRA pump tubing exceeds the industry's requirements for a flexible, clear, weldable and sealable pump tubing for fluid processing applications. C-Flex® ULTRA has also consistently outperformed every known competitor in extensive testing conducted by independent organizations. Three particularly important performance parameters stand out.

  • Pump life – C-Flex® ULTRA was still pumping after 1,400 hours of continuous operation (at 600 rpms with 15 pounds of back pressure).

  • Spallation – C-Flex® ULTRA delivers lower spallation during the pumping process than any other TPE or silicone formulation.

  • Surface smoothness – While other TPE tubing is plagued with surface tackiness, C-Flex® ULTRA's smooth outer surface does not gum up pump heads, reducing downtime for cleaning and resulting in far less wear and tear on these crucial pump components.

C-Flex® ULTRA complies with USP Class VI standards and is manufactured by Saint-Gobain Performance Plastics under strict cGMP guidelines. The tubing's unique, patented TPE formula is significantly less permeable than silicone, has low platelet adhesion and protein binding characteristics, and provides excellent clarity for easy viewing of fluid. It is BPA-free, phthalate-free and animal derived component-free (ADCF); non-pyrogenic and non-cytotoxic; and offers excellent resistance to concentrated acids and alkalis.

C-Flex® ULTRA can be thermally sealed and welded, making it ideal for biopharmaceutical filling and sampling processes. It is available in ten standard sizes (ID x OD), with custom sizes, lengths and packaging available upon request.

For more information on all Saint-Gobain Performance Plastics products for the pharmaceutical industry, visit

About Saint-Gobain Performance Plastics

Saint-Gobain Performance Plastics, part of the Innovative Materials Sector of Saint-Gobain, is headquartered in Aurora, Ohio, and employs 4,400 people in 15 countries.  It is a world leader in high-performance plastics, including flexible tubing applications, seals, coated fabrics, foams, polymer products and bearings.

About Saint-Gobain

Based in Paris, Saint-Gobain has operations in 64 countries and employs nearly 190,000 people. Founded in 1665 to manufacture glass for the Hall of Mirrors at the Palace of Versailles in Paris, Saint-Gobain remains headquartered in France and had worldwide sales of $53.2 billion in 2010. The company has 19,000 employees in more than 350 locations across the United States and Canada. For more information, visit and

For more information contact:
Linda Potter
Marketing Coordinator — Life Sciences
Tel: 727-299-2565

To download a photograph:

SOURCE Saint-Gobain Performance Plastics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System
2. Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada
3. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
4. Independent Investigator Initiates Phase 1 Study of Biodels Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
5. Boston Scientific Begins U.S. and International Launch of Expect™ Endoscopic Ultrasound Aspiration Needle
6. Volcano Corporation to Supply Intravascular Ultrasound Technology to Covidien for Integration with Plaque Excision Systems
7. United Imaging Healthcare Leverages Samplifys Analog Front-End Solutions to Deliver New Portable Ultrasound System with Superior Image Quality
8. TechniScans Breast Imaging Science Featured at National Ultrasound Conference
9. $2 Million Awarded to Duke University Prevention Epicenter to Study Reduction of Healthcare-Associated Infections Using Tru-D, Total Room Ultraviolet Disinfection
10. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
11. Reportlinker Adds Global Medical Ultrasound Equipment Industry
Post Your Comments:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):